bennyboy1 Friday, 10/19/18 11:44:35 AM Re: XenaLives post# 168783 Post # of 237447 ANAVEX gets important Rett Syndrome approval from FDA to begin!! Great news for all concerned, investors, buyers, the afflicted as well. Just put yourself in position as a parent, with great hope for a wonderful and helpful drug ahead to help their little girl - mindboggling! We can now go to CTAD and emphatically announce we are moving forward on 3-important trials for Alzheimer's, Parkinson's Dementia and Rett Syndrome, all under the banner of ANAVEX and 2-73! This is no JOKE - Big Pharma just raised their ears up!!! This announcement and further confirmatory data ahead on October 26th in Barcelona, Spain will cement us as a very serious and determined entry for many CNS Diseases! No doubt in my mind, as we pass important milestones the conversations about licensing, partnering or buyouts will get louder and louder as success comes forth! Success opens many doors and further confirms we are REAL and coming hard!!!!!!!!!